Theme: Vision towards Stroke, Neurological Disorders and Recovery

Stroke Meeting 2020

Stroke Meeting 2020

Emerging TargetVision towards Stroke, Neurological Disorders and Recovery Therapies and Trends in Stroke:  Cardio and Cerebrovascular Diseases

We are glad to announce annual meeting “11th International Conference on Stroke, Neurology and Cerebrovascular Diseases" to be held at Paris, France on October 19-20, 2020. Stroke Meeting 2020 is working under the theme: Vision towards Stroke, Neurological Disorders and Recovery”.

Neuroscience defines the systematic study of the mechanics of the central nervous system such as its structure, function, physiology, and genetics including by what means this can be related to understand diseases of the nervous system where as ‘Neurology’ is the branch of medicine that is concerned with diseases and disorders of the nervous system ranging from Alzheimer's disease, epilepsy, dementia & stroke, migraine respectively including neuroinfectious and brain tumors. Neurology includes diagnosing and treating conditions of the central, peripheral and autonomic nervous systems.

The field neurology includes a broad range of subspecialties few of them are child neurology, clinical neurophysiology, endovascular surgical neuroradiology, hospice & palliative medicine, neuromuscular medicine, sleep medicine, pain medicine, vascular neurology, autonomic disorders, behavioral neurology & neuropsychiatry, geriatric neurology, neural repair & rehabilitation medicine, neuroimaging, neuro-oncology, psychosomatic medicine, neurosurgery.

Neuroscience Conferences organizes about 3000+ global events including international conferences, symposia, trade shows, workshops, exhibitions and science congresses in all the major scientific disciplines, including medical, pharmaceutical, technology, clinical, engineering, business management & life sciences globally. Conference Series is conducting several Neuroscience/Psychiatric/Stroke events globally which focuses primarily on neurology, neurosurgery, neuro-oncology, and neuroimaging. These neurology conferences witness researchers, academic professors, pharmacists, physicians & surgeons who endeavour to disseminate their research experience to escalate the forthcoming research ideas.

Global Neurology Market embraces many of therapeutics used for the treatment of several neurological disorders. The novel pipeline, patent expiry of blockbuster drug and new drug approval has affected the neurology market and it is estimated to grow through the forecast period. The biopharmaceutical companies are investing substantially in the development of advanced therapeutics for the treatment of neurological disorders/diseases. Government organizations are sponsoring research and development activities related to neurology research. These factors are impacting the neurology market positively coupled with the growing prevalence of neurological disorders. The global neurology market is growing due to an increased aging population, expanding awareness regarding mental and neurological illness, increasing health insurance reforms and constant research and development in neurology by pharmaceutical companies. These factors and technological advances such as biomarkers, mobile applications, 3D printed drugs and wearable technologies used to monitor and treat patients diagnosed with neurological disorders are expected to drive the neurology drugs industry. 

Track 1 Neurology and Neurosurgery

Neurology is the branch of medicine that deals with disorders of the nervous system, which include the brain, blood vessels, muscles, and nerves. most areas of neurology are the autonomic, central and peripheral nervous systems. A physician who works within the field of neurology is named a neurologist. Neurosurgery is surgery of the nervous system. A physician who specializes in neurosurgery. Neurosurgeons aren't just brain surgeons, they're medically trained neurosurgical specialists who also can help patients affected by back and neck pain also as a number of other illnesses starting from trigeminal neuralgia to go injury and paralysis agitans.

Track 2 Stroke and Cerebrovascular Diseases

The common mode of expression of stroke could be a relatively sudden occurrence of a focal neurological deficit. Strokes are broadly categorized as ischemic or hemorrhagic. Ischemic stroke is due to occlusion of a cerebral blood vessel and causes cerebral infarction. Knowledge of the stroke syndromes, the signs, and symptoms that correspond to the region of the brain that's supplied by each vessel, allows a degree of precision in determining the particular vessel that's occluded and from the temporal evolution of the syndrome, the underlying explanation for vascular occlusion is often deduced. Cerebrovascular disease refers to a group of conditions, diseases, and disorders that affect the blood vessels and blood supply to the brain. Cerebrovascular disease can develop from a spread of causes, including atherosclerosis, where the arteries become narrow; thrombosis, or embolic blood clot, which may be a grume in an artery of the brain or cerebral phlebothrombosis which may be a blood clot during a vein of the brain.

Track 3 Epidemiology, Management and Prevention

Salmonella species are a group of Gram-negative enterobacteria and known human pathogens in developing as well as industrialized countries. Despite significant advances in sanitation, provision of potable water, and highly controlled food chain surveillance, transmission of Salmonella spp. continues to affect communities, preferentially children, worldwide. This review summarizes updated concepts on typhoidal and non-typhoidal Salmonella infections, starting with a historical perspective that implicates typhoid Salmonella as a significant human pathogen since ancient times. We describe the epidemiology of this pathogen with emphasis on the most recent non-typhoidal Salmonella outbreaks in industrialized countries and continued outbreaks of typhoid Salmonella in underserved countries. An overview of clinical aspects of typhoid and non-typhoid infections in developing and industrialized countries, respectively, is provided, followed by a description on current treatment concepts and challenges treating multidrug-resistant Salmonella infections. We conclude with prevention recommendations, and recent research studies on vaccine prevention.

Track 4 Stroke Rehabilitation and Brain Hemorrhage

A brain hemorrhage may be a variety of stroke. It's caused by an artery within the brain bursting and causing localized bleeding in the surrounding tissues. This bleeding kills brain cells.  A stroke will cause lasting brain injury. people who survive a stroke have to be compelled to acquire skills they lost because of the injury. Rehabilitation will help them acquire those skills.

  • The effects of a stroke depend on that area of the brain was damaged. the categories of disabilities a stroke can cause include
  • paralysis or problems controlling movement
  • Pain and alternative issues with the senses
  • problems using or understanding language
  • problems with thinking and memory
  • Emotional disturbances

Track 5 Ischemic Stroke and Transient Ischemic Attack

Ischemic stroke occurs when an artery to the brain is blocked.  The brain depends on its arteries to bring contemporary blood from the heart and lungs. The blood carries oxygen and nutrients to the brain and takes away carbon dioxide and cellular waste. If an artery is blocked, the brain cells cannot create enough energy and can eventually stop working. A transient ischemic attack may be a stroke that lasts only a number of minutes. It happens once the blood supply to a part of the brain is briefly blocked. Symptoms of a transient ischemic attack are like alternative stroke symptoms however don't last as long. They happen suddenly and include

  • Numbness or weakness, especially on one side of the body
  • Confusion or trouble speaking or understanding speech
  • Trouble seeing in one or both eyes
  • Difficulty walking
  • Dizziness
  • Loss of balance or coordination

Track 6 Cryptogenic Stroke and Antiplatelet Therapy

In most cases, a stroke is caused by a blood clot that blocks blood flow to the brain. However in some instances, despite testing, the cause can’t be determined. Strokes while not a known cause are referred to as cryptogenic. That’s why it’s necessary to dig deeper for a definitive diagnosis. Collaboration by neurologists, cardiologists, electrophysiologists, and others might reveal the answers required to supply targeted treatment for preventing recurrent strokes. Antiplatelets are a bunch of medicines that stop blood cells from sticking together and forming a blood clot. Whenever there's an injury in your body, platelets are sent to the site of the injury, wherever they clump along to make a blood clot. This stops the bleeding in your body.

Patients are usually given antiplatelets if they have a history of

  • Coronary artery disease (CAD)
  • Heart attack
  • Angina
  • Stroke or transient ischemic attacks (TIAs)
  • Peripheral vascular disease (PVD)

Track 7 Risk factors, Diagnosis, Medications and Recovery

History could include asking about what symptoms are present, once they began, and if they're rising, progressing, or remaining a similar. Past medical history can look for stroke risk factors, medications, allergies, and any recent sicknesses or surgeries. Medication history is extremely necessary, particularly when the patient is taking anticoagulants warfarin, dabigatrin, rixaroxiban, apixaban, enoxaparin. Physical examination includes assessing vital signs and patient wakefulness. A neurological examination is performed, typically using the standardized stroke scale. Heart, lungs, and abdomen are also assessed. specialised stroke centers -- hospitals that have the doctors, equipment, and resources to intervene quickly and treat strokes aggressively -- have shown to increase stroke survival similarly as patient function and recovery.

Track 8 Cardiovascular and Stroke Nursing

Cardiovascular disease may be a category of diseases that involve the heart or blood vessels. CVD includes coronary artery diseases like angina and myocardial infarction different CVDs include stroke, heart failure, hypertensive heart condition, rheumatic heart condition, cardiomyopathy, abnormal heart rhythms, congenital heart condition, valvular heart condition, carditis, aortic aneurysms, peripheral artery sickness, thromboembolic sickness, and thrombosis.

  • Physiological monitoring and maintenance of homeostasis
  • Reduce morbidity and prevent mortality
  • Prevent and observe lesion extension and cerebral oedema
  • Prevent complications
  • Understand stroke aetiology
  • Assess potential/ Facilitate recovery
  • Multi-disciplinary assessment and input
  • Prevent recurrent stroke

Track 9 Heart Failure and Heart Diseases

Heart failure, generally called congestive heart failure, happens once your muscle doesn't pump blood likewise as a result of it ought to. certain conditions, like narrowed arteries in your heart or high force per unit area, gradually leave your heart too weak or stiff to fill and pump efficiently. cardiopathy describes a range of conditions that have an impact on your heart. Diseases under the heart disease umbrella include blood vessel diseases, like coronary artery disease; heart rhythm problems and heart defects you're born with, among others.Shortness of breath once you exert yourself or when you lie down

  • Fatigue and weakness
  • Swelling in your legs, ankles, and feet
  • Chest pain, chest tightness, chest pressure, and chest discomfort
  • Shortness of breath
  • Pain, numbness, weakness or coldness in your legs or arms if the blood vessels in those components of your body are narrowed
  • Pain within the neck, jaw, throat, upper abdomen or back

Track 10 Cardiac Arrest and Recovery

A cardiac arrest usually happens without warning. If somebody is in cardiac arrest, they collapse suddenly and will be unconscious, unresponsive, and won't be respiration or breathing ordinarily - not breathing normally could mean they’re making gasping noises. Immediate recovery: when a cardiac arrest, you’ll are taken care of in a coronary care or medical aid unit. you may have been put in associate induced coma and kept asleep to permit your body to recover. Mid-term recovery: Doctors and cardiologists can need to figure out what caused the cardiac arrest. they will then recommend medication and treatment, such as a pacemaker or implantable cardioverter electronic device (ICD), to reduce the risk of it happening once more. long recovery: it'll take time to recover when a cardiac arrest, however your doctor can support you throughout now. seek advice from family and doctors regarding what's going to happen once you go back and sensible matters, like driving and returning to figure.

Track 11 Geriatric Cardiology and Palliative Care

The geriatric cardiologist involves see the cardiovascular system within a perspective of associate aging body that's probably to be frail, noncompliance, disorganized, and confused, experiencing impaired operate of many organ systems, and damage from earlier diseases. Poor lifestyle-choices, inadequate preventive health habits, consuming a good sort of frequently prescribed medications and in a situation wherever the parsimony of science now not applies, the prevalence of systolic and diastolic heart disease, cardiac arrhythmia, aortic stenosis, and electrical conduction defects will increase with age, leading to a major burden of cardiovascular disease. Palliative care is specialized medical care for people living with a serious health problem, this kind of care is concentrated on providing relief from the symptoms and stress of the health problem. The goal is to enhance the standard of life for each patient and the family. Palliative care is based on the needs of the patient, not on the patient’s prognosis. Its right at any age and at any stage in a serious health problem, and it is provided along with curative treatment.

Track 12 Cardiac Nursing and Health Care

Cardiac nursing could be a specialty focused on preventing and treating conditions associated with the heart. Like alternative nursing specialties, a profession in cardiac nursing needs an understanding of normal cardiac anatomy and physiology, keen assessment and observance skills, vast information on cardiac disease and conditions, and in-progress education associated with counseled interference strategies and treatment options. Cardiac nurses may work in inpatient or outpatient settings, care for medical or surgical patients, and see patients through acute illness or help them manage chronic illness.

Track 13 Hypertension and Cardiovascular Research

Hypertension is often referred to as the silent killer as there aren't any directly visible symptoms that occur in patients. In several cases, the diagnosis is made only if alternative medical conditions associated with the heart, arteries, kidneys or brain crop up. It’s thus essential to realize detailed info concerning hypertension and its types. Even as there aren't any symptoms, the causes of high blood pressure are unknown in virtually 90% of the cases. Factors like family history of high BP, age, gender, obesity, smoking, drinking, and an inactive mode among others are possible reasons for developing high blood pressure although they continue to be inconclusive. Cardiovascular is elating to the circulatory system, which includes the center and blood vessels and carries nutrients and oxygen to the tissues of the body and removes carbon dioxide and alternative wastes from them. Cardiovascular diseases are conditions that have an effect on the heart and blood vessels and include hardening of the arteries, artery illness, heart valve illness, arrhythmia, heart failure, high blood pressure, hypotension, shock, endocarditis, diseases of the artery and its branches, disorders of the peripheral vascular system, and congenital heart disease.

Track 14 Cardiac Surgery and Heart Regeneration

Cardiac surgery is surgery on the heart or great vessels performed by cardiac surgeons. It is often used to treat complications of ischemic heart condition to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis. It also includes heart transplantation. Cardiac surgery is the specialty of medicine concerning the surgery of pathologies associated with the heart and thoracic aorta. Heart regeneration may be a broad effort that aims to repair irreversibly damaged heart tissue with cutting-edge science, including stem cell and cell-free therapy. Reparative tools are engineered to restore damaged heart tissue and performance using the body's natural ability to regenerate. Working together, patients and providers are finding regenerative solutions that restore, renew and recycle patients' own reparative capacity.

Track 15 Alzheimer’s Disease and Dementia

Dementia and Alzheimer’s disease aren’t an equivalent . Dementia is an overall term used to describe symptoms that impact memory, performance of daily activities, and communication abilities. Alzheimer’s disease is that the most common sort of dementia. Alzheimer’s disease gets worse with time and affects memory, language, and thought. While younger people can develop dementia or Alzheimer’s disease, your risk increases as you age. Still, neither is considered a normal part of aging. Although symptoms of the two conditions may overlap, distinguishing them is vital for management and treatment. Dementia may be a syndrome, not a disease. A syndrome may be a group of symptoms that doesn’t have a definitive diagnosis. Dementia may be a group of symptoms that affects mental cognitive tasks like memory and reasoning. Dementia is that the term applied to a group of symptoms that negatively impact memory, but Alzheimer’s may be a progressive disease of the brain that slowly causes impairment in memory and cognitive function. the exact cause is unknown and no cure is out there.

Track 16 Neuroscience and Neuroimaging

Neuroscience is that the scientific study of the nervous system. It is an interdisciplinary science that combines and draws on multiple fields, from molecules to medicine. Neuroscience is that the study of how the nervous system develops, its structure, and what it does. Neuroscientists specialise in the brain and its impact on behavior and cognitive functions. Not only is neuroscience concerned with the normal functioning of the nervous system, but also what happens to the nervous system when people have neurological, psychiatric and neurodevelopmental disorders. Neuroscience is usually mentioned within the plural, as neurosciences. Neuroimaging is the discipline that deals with the in vivo depiction of anatomy and function of the central nervous system (CNS) in health and disease. Neuroimaging encompasses the varied techniques wont to image the structure of the brain, and it is relevant to some health science disciplines, where it's an excellent impact on the understanding, diagnosis, and treatment of neurological diseases.

Track 17 Neurophysiology and Neurodegeneration

Neurophysiology is broadly defined because the study of nervous system function. In this field, scientists investigate the central and peripheral nervous systems at the extent of whole organs, cellular networks, single cells, or maybe subcellular compartments. A unifying feature of this wide-ranging discipline is an interest within the mechanisms that cause the generation and propagation of electrical impulses within and between neurons. This subject is vital not just for our understanding of the fascinating processes driving human thought but also for our ability to diagnose and treat disorders associated with nervous system malfunction. Neurodegeneration may be a complex multifactorial process that causes neuronal death within the brain and spinal cord, leading to brain and spinal cord damage and dysfunction.

  • Alzheimer's disease
  • Amyotrophic lateral sclerosis
  • Friedreich's ataxia
  • Huntington's disease
  • Lewy body disease
  • Parkinson's disease
  • Spinal muscular atrophy 

Track 18 Neurological Disorders and Neuroplasticity

Neurological disorders are diseases of the central and peripheral nervous system. In alternative words, the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscles. These disorders embody epilepsy, Alzheimer's sickness, and alternative dementias, vessel diseases also as stroke, migraine, and alternative headache disorders, multiple sclerosis, Parkinson's illness, neuroinfections, brain tumours, traumatic disorders of the systema nervosum due to head trauma, and neurological disorders as a results of malnutrition. Neuroplasticity is that the brain's ability to reorganize itself by forming new neural connections throughout life. Neuroplasticity permits the neurons within the brain to catch up on injury and illness and to manage their activities in response to new situations or to changes in their environment.

Track 19 Computational Neuroscience and Neural Networks

Computational neuroscience is the only subject that will let you understand, how you’re capable of think and process statistics on your mind. There will be a great number of actions occurring interior your mind which can be decoded by using the examine of neurons. The ultimate goal of computational neuroscience is to give an explanation for how electrical and chemical signals are used inside the mind to represent and process information. It explains the biophysical mechanisms of computation in neurons, computer simulations of neural circuits, and models of learning. Neural networks represent one stage of employer that is modelled computationally in mind research. Computational neuroscience attempts to make these as biologically practical as possible, often creating fashions that function at multiple levels, including having the neural networks showcase electrochemical dynamics.

Track 20 Clinical Trials and Case Reports

Two forms of clinical research are Interventional Studies and Observational Studies. A clinical study involves a couple of patients. In an observational study, investigators investigate health outcomes in groups of participants in keeping with a research plan or protocol. Participants may acquire interventions or processes as part of their ordinary scientific care, however, participants aren't assigned to specific interventions by the investigator. In medicine, a case record is a detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of a person patient. Case reviews may contain a demographic profile of the patient but usually describe an uncommon or novel occurrence. Research has a look at the usage of human topics to assess biomedical or health-related outcomes.

Track 21 Biomarkers and Clinical Research

A biomarker shows a biological molecule or gene this is used to efficiently and correctly examine pharmacologic responses, pathogenic procedures, and organic procedures. Also known as a molecular marker or signature molecule, biomarkers are detected in blood, other body fluids, and tissue. The global marketplace for biomarkers is gaining traction from several factors, along with prevalence and prognosis of life-threatening diseases like cancer, cardiovascular diseases, neurological disorders, etc., that's, in turn, raising the attention and growing the call for early prognosis, reducing value of medical trials in numerous emerging economies, growing investment in studies and improvement via biotechnology and pharmaceutical companies, and new initiatives approximately biomarker research. On the other hand, the biomarkers market is facing challenges from high capital investments, the low price-advantage ratio with total investment, and badly suited regulatory and reimbursement systems.

Vision towards Stroke, Neurological Disorders and Recovery

We invite all the participants throughout the world to join us for the upcoming “11th International Conference on Stroke, Neurology and Cerebrovascular Diseases to be held on October 19-20, 2020 at Paris, France.

The scope of this report is broad and includes therapeutics used in the treatment of neurological disorders. The market analysis of neurology represents the largest and untapped market in medicine sector. This estimated market analysis is based on probability of approval and sales of products in late stage development, demographic trends and marketing of product. Emerging markets once again helps to boost revenues. CNS therapeutics covers approximately 15% of total pharmaceutical sales, almost $30 billion worldwide. The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024. International neurology market consists of various therapeutics used for the treatment of different neurological disorders, the novel pipeline, patent expiry of blockbuster drug and new drug approval have affected the neurology market and it is estimated to grow during the forecast period. The biopharmaceutical companies are financing significantly in the development of innovative therapeutics for the treatment of neurological disorders. Government organizations are funding research & development related to neurology research. These factors are influencing the neurology market positively coupled with the growing prevalence of neurological disorders. The improved government funding in neurology research and an ever-growing demand for research centred on drug discovery for enhancement of novel therapies in neurological disorders are driving the growth of neurology market. The global market for psychotic disease is predicted to grow at a slow rate during the forecast period.

The slow progress is attributed primarily to the loss of patent exclusivity of branded drugs and the emergence of generic drugs. Manufacturers of branded drugs are expected to experience a decline in sales revenue due to the penetration of low-cost generic drugs in the market, which is likely to influence the growth of the market for antipsychotic drugs. New approaches for the treatment of neurology related indications were pursued by pharmaceutical companies. This new drug with a novel method of action or improved delivery system will present a powerful new option to currently prescribed neurology medicines. The global neurology market is growing due to a rise in the aging population, increased awareness regarding mental & neurological illness, increasing health insurance reforms and constant research & development in neurology by pharmaceutical companies. These factors along with technological advances such as 3D printed drugs, biomarkers, wearable technologies and mobile applications used to monitor and treat patients diagnosed with neurological disorders are expected to drive the neurology drugs industry. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on drug manufacturers' total revenues. Projected and forecasted revenue values are in constant US dollars, unadjusted for inflation. European neurological disorders have been depicted in the below graph.

The 7th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series was held during July 31- August 02, 2017 at Hilton Garden Inn Milan North, Milan, Italy  Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

We expresses our gratitude to the conference Moderators, namely Dr. Jong Eun Lee, Dr. Mariya Hristova and Dr. Maha Nada for taking up the responsibility to co-ordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Hari Shanker Sharma, Uppsala University, Sweden

Stephen D Skaper, University of Padua, Italy

David Truswell, Somefreshthinking Consultancy, UK

Michael V Ugrumov, Institute of Developmental Biology RAS, Russia

Ni Hong, Soochow University, China

M Cohen-Armon, Tel-Aviv University, Israel

Istvan Berczi, University of Manitoba, Canada

We are grateful to our Spekaers of Special session. The list comprises:

Harish C Pant, National Institutes of Health, USA

Yacov Rofé, Bar-Ilan University, Israel

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Neuro Immune Pharmacology
Molecular Neuropharmacology
Neurochemical Transmission
Behavioral Neuropharmacology
Alzheimer’s Disease and Dementia
Parkinson’s Disease
Future Aspects of Neuropharmacology
Clinical Neuropharmacology
Chemical Neurotransmitters
Case Study Reports
Entrepreneurs Investment Meet

We offer our   heartfelt appreciation to organizations such as Bentham Science and our esteemed supporters SelectScience Trade Show Alerts  Medgenera Crowd Reviews PBR Clinical Biometrics Bio-Equip Nanobay Pharma Focus Asia ManuscriptEdit Times International eindiabusiness  and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. We also took the privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Neuropharmacology 2017, We are proud to announce the "11th International Conference on Stroke, Neurology and Cerebrovascular Diseases" to be held during October 19-20, 2020 in Paris, France.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 19-20, 2020
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1
Poster Opportunity Closed Click Here to View